Akoya Biosciences Inc (AKYA)

May 23, 2025, 2:21 PM EDT - 12 days ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

QTRX

May 12, 2025, 4:05 PM EDT - 23 days ago

Akoya Biosciences Reports First Quarter 2025 Financial Results

May 7, 2025, 3:46 PM EDT - 4 weeks ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

QTRX

Apr 30, 2025, 8:00 AM EDT - 5 weeks ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

QTRX

Apr 29, 2025, 7:00 AM EDT - 5 weeks ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

QTRX

Apr 24, 2025, 8:00 AM EDT - 5 weeks ago

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

Apr 24, 2025, 8:00 AM EDT - 5 weeks ago

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

Apr 23, 2025, 8:00 AM EDT - 6 weeks ago

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

Apr 14, 2025, 8:00 AM EDT - 7 weeks ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

QTRX

Apr 7, 2025, 8:15 AM EDT - 2 months ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

QTRX

Apr 2, 2025, 8:00 AM EDT - 2 months ago

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

Mar 24, 2025, 8:00 AM EDT - 2 months ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

QTRX

Mar 17, 2025, 4:00 PM EDT - 2 months ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

QTRX

Mar 17, 2025, 4:00 PM EDT - 2 months ago

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Mar 11, 2025, 8:00 AM EDT - 3 months ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

QTRX

Feb 18, 2025, 3:40 PM EST - 3 months ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

QTRX

Feb 5, 2025, 8:00 AM EST - 4 months ago

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Jan 28, 2025, 6:00 AM EST - 4 months ago

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner

Jan 10, 2025, 7:00 AM EST - 5 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

QTRX

Dec 10, 2024, 8:15 AM EST - 6 months ago

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nov 14, 2024, 9:43 PM EST - 7 months ago

Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:00 PM EST - 7 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 8:30 AM EDT - 7 months ago

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 7, 2024, 8:00 AM EDT - 8 months ago

Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

Oct 3, 2024, 4:00 PM EDT - 8 months ago

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

Aug 5, 2024, 10:19 PM EDT - 10 months ago

Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:00 PM EDT - 10 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results

Jul 15, 2024, 4:00 PM EDT - 11 months ago

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

BNGO CTKB DHR LAB MASS OMIC QGEN

May 17, 2024, 8:36 PM EDT - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:00 PM EDT - 1 year ago

Akoya Biosciences Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

May 6, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

May 2, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Apr 22, 2024, 4:05 PM EDT - 1 year ago

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Apr 5, 2024, 8:00 AM EDT - 1 year ago

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider

Mar 4, 2024, 8:17 PM EST - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:05 PM EST - 1 year ago

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Feb 8, 2024, 4:05 PM EST - 1 year ago

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Jan 18, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Jan 10, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D.

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

Dec 20, 2023, 8:05 AM EST - 1 year ago

Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023, 7:45 AM EST - 1 year ago

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Nov 11, 2023, 12:49 AM EST - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q3 2023 Earnings Call Transcript